Evidence map›Paper›PMID 18194515›Full record

ArticleMalaria journal2008

Polymorphisms of TNF-enhancer and gene for FcgammaRIIa correlate with the severity of falciparum malaria in the ethnically diverse Indian population.

Swapnil Sinha, Shrawan K Mishra, Shweta Sharma, Phani K Patibandla, Prashant K Mallick, Surya K Sharma, Sanjib Mohanty, Sudhanshu S Pati, Saroj K Mishra, Bheshaj K Ramteke and 8 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Review
  8. Article
  9. Article
  10. Susceptibility toFrontiers in immunology · 2020
    Article
  11. Interleukin-22 Polymorphisms inMediators of inflammation · 2020
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Swapnil SinhaDivision of Molecular and Structural Biology, Central Drug Research Institute, Post box 173, Chattar Manzil, Mahatma Gandhi Marg, Lucknow-226001, India. swaps_24@yahoo.com
Shrawan K Mishra
Shweta Sharma
Phani K Patibandla
Prashant K Mallick
Surya K Sharma
Sanjib Mohanty
Sudhanshu S Pati
Saroj K Mishra
Bheshaj K Ramteke
Rm Bhatt
Hema Joshi
Aditya P Dash
Ramesh C Ahuja
Shally Awasthi
Indian Genome Variation Consortium
Vimala Venkatesh
Saman Habib
Central Drug Research Institute · INKing George's Medical University · INNational Institute of Malaria Research · INIspat General Hospital · INNational Institute of Technology Rourkela · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSusceptibility/resistance to Plasmodium falciparum malaria has been correlated with polymorphisms in more than 30 human genes with most association analyses having been carried out on patients from Africa and south-east Asia. The aim of this study was to examine the possible contribution of genetic variants in the TNF and FCGR2A genes in determining severity/resistance to P. falciparum malaria in Indian subjects.

methodsAllelic frequency distribution in populations across India was first determined by typing genetic variants of the TNF enhancer and the FCGR2A G/A SNP in 1871 individuals from 55 populations. Genotyping was carried out by DNA sequencing, single base extension (SNaPshot), and DNA mass array (Sequenom). Plasma TNF was determined by ELISA. Comparison of datasets was carried out by Kruskal-Wallis and Mann-Whitney tests. Haplotypes and LD plots were generated by PHASE and Haploview, respectively. Odds ratio (OR) for risk assessment was calculated using EpiInfotrade mark version 3.4.

resultsA novel single nucleotide polymorphism (SNP) at position -76 was identified in the TNF enhancer along with other reported variants. Five TNF enhancer SNPs and the FCGR2A R131H (G/A) SNP were analyzed for association with severity of P. falciparum malaria in a malaria-endemic and a non-endemic region of India in a case-control study with ethnically-matched controls enrolled from both regions. TNF -1031C and -863A alleles as well as homozygotes for the TNF enhancer haplotype CACGG (-1031T>C, -863C>A, -857C>T, -308G>A, -238G>A) correlated with enhanced plasma TNF levels in both patients and controls. Significantly higher TNF levels were observed in patients with severe malaria. Minor alleles of -1031 and -863 SNPs were associated with increased susceptibility to severe malaria. The high-affinity IgG2 binding FcgammaRIIa AA (131H) genotype was significantly associated with protection from disease manifestation, with stronger association observed in the malaria non-endemic region. These results represent the first genetic analysis of the two immune regulatory molecules in the context of P. falciparum severity/resistance in the Indian population.

conclusionAssociation of specific TNF and FCGR2A SNPs with cytokine levels and disease severity/resistance was indicated in patients from areas with differential disease endemicity. The data emphasizes the need for addressing the contribution of human genetic factors in malaria in the context of disease epidemiology and population genetic substructure within India.

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideAfricaAntigens, CDAsia, SoutheasternEnzyme-Linked Immunosorbent AssayGene FrequencyGenotypeHaplotypesHumansIndiaMalaria, FalciparumOdds RatioReceptors, IgGSeverity of Illness IndexTumor Necrosis Factor-alphaAntigens, CDFc gamma receptor IIAReceptors, IgGTNF protein, humanTumor Necrosis Factor-alpha

Identifiers

PMID18194515
PMCPMC2245971
OpenAlexW2043394305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.